Emyria Ltd capitalises on Cann Group Ltd collaboration to progress EMD-003 CBD medicine for mental health
Deep Dive - Emyria Ltd
Source: proactiveinvestors.com.au
📰 Emyria Data News
Emyria Data News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Emyria Data. Real-time updates on events, politics, business and more.
Emyria Ltd begins recruiting for EMD-RX5 Phase 1 clinical safety and bioavailability study
Emyria Ltd (ASX:EMD) has started participant recruitment, screening and consenting for its Phase 1 clinical trial of EMD-RX5, with dosing expected to begin...
United States Michael Winlo Emyria Ltd Drug Administration Therapeutic Goods Administration Real World Data
Source: proactiveinvestors.com.au
Emyria Ltd enhances growth strategy with appointment of Sixty Two Capital as corporate advisor
“Sixty Two Capital has a track record of supporting high growth client companies over the long-term,” says MD.
Source: proactiveinvestors.com.au
Emyria Ltd's ultra-pure CBD capsule outperforms TGA-approved CBD treatment in pre-clinical animal trial
“These animal study results suggest Emyria has developed a novel, high performing and cost-effective CBD capsule that can meet the strict...
United States Michael Winlo Emyria Ltd Us Federal Drugs Administration Therapeutic Goods Administration Therapeutics Goods Administration Approved
Source: proactiveinvestors.com.au
Emyria Ltd passes MDMA analogue development milestone with Eurofins to lead extensive compound screening program
“We are pleased to be working with global leader Eurofins to screen our first batch of novel MDMA-analogues after successfully completing...
Matt Piggott Michael Winlo Palantir Foundry Builders Program Therapeutic Goods Administration University Of Western Australia Western Australia
Source: proactiveinvestors.com.au
Emyria Ltd buoyed by TGA-commissioned Independent Expert Report on MDMA and psilocybin
The Therapeutic Goods Administration released an Independent Expert Panel Report reviewing the therapeutic potential of MDMA and psilocybin ahead of...
Michael Winlo Expert Panel Advisory Committee Of Medicines Scheduling Independent Expert Panel Post Traumatic Stress Disorder Mind Medicine Australia
Source: proactiveinvestors.com.au
LIfescience innovators to feature in Proactive Lifesciences Webinar next Tuesday
Join three emerging lifescience companies as they present their investment cases at Proactives Lifesciences Webinar at 12pm AEST on Tuesday, September...
Source: proactiveinvestors.com.au
Emyria Ltd has project data validated with care model reducing opioid use and opening new opportunities
The data show that on average opioid consumption reduces after commencing care at Emerald Clinics from a previous 12 month steady-state of opioid use.
Source: proactiveinvestors.com
Why the Emyria (ASX:EMD) share price is climbing 7% higher today
The Emyria Ltd (ASX: EMD) share price is climbing following a positive announcement to service its growing demand. We take a closer look.
Western Australia Scott Phillips Michael Winlo Australian Therapeutic Goods Administration Emyria Ltd Health Research
Source: fool.com.au